tirzepatide 5 mg 0.5 ml solution pen injector MOUNJARO 12.5 / ( ) FOR SUBCUTANEOUS INJECTION 4 PRE-FILLED PENS 1) receptor agonist Mounjaro. 5mg.

Last Reviewed: Q4 2025 Originally developed to treat Type 2 Diabetes, GLP-1s have since gained FDA approval for a variety of diseases, with new indications continually emerging

Because it was associated with excessive urine, ancient Greek physicians called the disease 'diabetes, which they took from the Greek word for 'siphon to reflect their observation that fluids flowed through diabetic patients like a siphon (Harris)

The problem is that this preference, while valid from a quality-of-life perspective, trades efficacy for comfort without data showing that the trade is worthwhile long-term

After reconstitution with bacteriostatic water, refrigerate and handle under appropriate laboratory conditions

The practical result for most people is reduced food noise